群栄化学工業 announced that it had revised current fiscal-year ordinary profit upward by 10%, from the previous forecast of ¥3.0 billion to ¥3.3 billion. Cumulative second-quarter ordinary profit was ¥2.39 billion, up 58.6% year on year, while second-half ordinary profit is expected to decline to ¥900 million.
群栄化学工業 announced its results on the afternoon of 30 October, reporting consolidated ordinary profit of ¥2.39 billion for the cumulative second quarter of FY22/the next fiscal period, up 58.6% year on year. As first-half results, consolidated ordinary profit for the July–September period was ¥1.25 billion, while net sales increased from the previous fiscal year and the operating margin improved significantly.
The full-year earnings forecast was revised upward from ¥3.0 billion to ¥3.3 billion, with the expected growth rate expanding from 1.4% to 11.5%. Revised EPS was also increased.
For the second-half outlook, consolidated ordinary profit for the October–March period is expected to fall significantly year on year, with the calculation indicating ¥900 million. In the latest three-month period, ordinary profit for July–September increased to ¥1.25 billion, confirming an improvement in profit margins.